Progyny, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Progyny, Inc. (PGNY) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $8.77 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2022-03-01
- Progyny, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2020-12-31 was $11.89M.
- Progyny, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2020-09-30 was -$9.15M.
- Progyny, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2020-06-30 was -$42.08M.
- Progyny, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2020-03-31 was -$693.00K.
- Progyny, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2021 was $8.77M.
- Progyny, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2020 was -$40.03M.
- Progyny, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2019 was -$2.96M.
- Progyny, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2018 was -$579.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2021-12-31 | $8.77M 10-K · filed 2022-03-01 | |||
| 2020-12-31 | $11.89M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.74M derived: sum of 2 quarters · filed 2022-03-01 | -$39.34M derived: sum of 3 quarters · filed 2022-03-01 | -$40.03M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$9.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$51.23M derived: sum of 2 quarters · filed 2020-11-06 | -$51.92M 10-Q · filed 2020-11-06 | -$54.20M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$42.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$42.77M 10-Q · filed 2020-08-07 | -$45.05M derived: sum of 3 quarters · filed 2022-03-01 | -$45.47M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$693.00K 10-Q · filed 2020-05-14 | -$2.97M derived: sum of 2 quarters · filed 2022-03-01 | -$3.39M derived: sum of 3 quarters · filed 2022-03-01 | -$3.52M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$2.70M derived: sum of 2 quarters · filed 2022-03-01 | -$2.83M derived: sum of 3 quarters · filed 2022-03-01 | -$2.96M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$420.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$553.00K derived: sum of 2 quarters · filed 2020-11-06 | -$678.00K 10-Q · filed 2020-11-06 | -$856.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$258.00K 10-Q · filed 2020-08-07 | -$436.00K derived: sum of 3 quarters · filed 2021-03-01 | |
| 2019-03-31 | -$125.00K 10-Q · filed 2020-05-14 | -$303.00K derived: sum of 2 quarters · filed 2021-03-01 | ||
| 2018-12-31 | -$178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$579.00K 10-K · filed 2021-03-01 | ||
| 2018-09-30 | -$401.00K 10-Q · filed 2019-12-06 | |||
| 2017-12-31 | -$612.00K 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |